Filing Details
- Accession Number:
- 0001209191-11-040744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-25 13:10:42
- Reporting Period:
- 2011-07-21
- Filing Date:
- 2011-07-25
- Accepted Time:
- 2011-07-25 13:10:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242879 | David Urdal | 3005 First Avenue Seattle WA 98121 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-07-21 | 1,015 | $38.75 | 576,080 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Billionaire Hedge Funds
